{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:47:58Z","timestamp":1785779278366,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the frequency of abnormal laboratory test results in pregnancy-associated hypertension and the relationship with pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a secondary analysis of a multicenter trial of vitamin C and E for prevention of pregnancy-associated hypertension in low-risk nulliparous women. Laboratory abnormalities included: platelets less than 100,000\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , aspartate aminotransferase 100 units\/L or greater, creatinine 1.5 mg\/dL or greater, lactate dehydrogenase 600 units\/L or greater, total bilirubin 1.2 mg\/dL or greater, or evidence of hemolysis on peripheral smear. Mild pregnancy-associated hypertension was defined as blood pressure 140\u2013159\/90\u2013109 mm Hg. Severe pregnancy-associated hypertension was defined as persistent blood pressure 160\/110 mm Hg or greater, acute antihypertensive treatment, or any blood pressure elevation associated with clinical signs of end-organ dysfunction (one or more of headache, epigastric pain, blurred vision, pulmonary edema, eclampsia, or oliguria). Pregnancy outcomes were compared across four groups: I, mild hypertension alone; II, mild hypertension+abnormal laboratory values; III, severe pregnancy-associated hypertension alone; and IV, severe pregnancy-associated hypertension+abnormal laboratory values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of 9,969 women, 2,752 (27.9%) developed pregnancy-associated hypertension and of these, laboratory abnormalities occurred in 7.3%. Laboratory abnormalities increased with severity of hypertension: mild hypertension alone (4.9%), severe hypertension alone (8.9%), and mild or severe hypertension with clinical signs of end-organ dysfunction (12.2%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend&lt;.001). Compared with women with mild hypertension alone, the adjusted odds for the perinatal composite (2-fold to 4.8-fold in Category III\u2013IV), preterm birth (2.1-fold to 7.8-fold in Category II\u2013IV), and other adverse perinatal outcomes increase with disease severity, particularly with laboratory abnormalities and severe clinical signs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>The frequency of abnormal laboratory values in women with pregnancy-associated hypertension increases with disease severity. Adverse perinatal outcomes increase in the presence of abnormal laboratory values, particularly in those with clinical signs, likely atttributable in part to the decision to deliver early.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>II<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000000509","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T08:41:30Z","timestamp":1412671290000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Laboratory Abnormalities in Pregnancy-Associated Hypertension"],"prefix":"10.1097","volume":"124","author":[{"given":"Jessica","family":"Cantu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Leveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Myatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Varner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Wapner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Peaceman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Ramin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sciscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20260528","first-page":"159","article-title":"ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists.","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R3-11-20260528","first-page":"S1","article-title":"Am J Obstet G","volume":"183","year":"2000","journal-title":"ynecol"},{"key":"R4-11-20260528","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1479-828X.2005.00382.x","article-title":"Routine investigations might be useful in pre-eclampsia, but not in gestational hypertension.","volume":"45","author":"Bailey","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R5-11-20260528","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0002-9378(93)90043-I","article-title":"Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).","volume":"169","author":"Sibai","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R6-11-20260528","first-page":"181","article-title":"Diagnosis and management of gestational hypertension and preeclampsia.","volume":"102","author":"Sibai","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R7-11-20260528","first-page":"648","article-title":"Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome Acta Obstet Gynecol S","volume":"86","author":"Cavkaytar","year":"2007","journal-title":"cand"},{"key":"R8-11-20260528","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1067\/mob.2000.105915","article-title":"Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.","volume":"183","author":"Haddad","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R9-11-20260528","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJMoa0908056","article-title":". Vitamins C and E to prevent complications of pregnancy-associated hypertension.","volume":"362","author":"Roberts","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-11-20260528","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM200002243420802","article-title":". Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.","volume":"342","author":"Carey","year":"2000","journal-title":"N Engl J Med"},{"key":"R11-11-20260528","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A United States reference for fetal growth.","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R12-11-20260528","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.","volume":"175","author":"Audibert","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R13-11-20260528","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia.","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"R14-11-20260528","first-page":"24","article-title":". Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group.","volume":"95","author":"Hauth","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R15-11-20260528","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1067\/mob.2002.120080","article-title":". Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.","volume":"186","author":"Buchbinder","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R16-11-20260528","first-page":"221","article-title":"Neonatal outcome in severe preeclampsia at 24 to 36 weeks gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter Am J Obstet G","volume":"180","author":"Abramovici","year":"1999","journal-title":"ynecol"},{"key":"R17-11-20260528","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R18-11-20260528","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy.","volume":"122","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201411000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:01:23Z","timestamp":1779980483000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201411000-00011"}},"subtitle":["Frequency and Association With Pregnancy Outcomes"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000000509","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}